Company / Depreciation & Amortization
Design Therapeutics, Inc. Depreciation & Amortization History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$596.0K
FY2025
5-year range
$5.0K / $596.0K
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $5,000 to $596,000 over the past 4 years.
Based on SEC 10-K filings.
$596,000 in FY2025.
Increased from $5,000 to $596,000 over the past 4 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 11.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $596.0K | +11.0% |
| FY2024 | $537.0K | +10640.0% |
| FY2021 | $5.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026